Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The related topics section now includes Prostate cancer and MedlinePlus Genetics, linking to educational resources.
    Difference
    0.2%
    Check dated 2026-07-10T23:51:46.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor site update to the page template or backend without altering the study content.
    Difference
    0.1%
    Check dated 2026-07-03T21:47:19.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.6.0 to v3.6.2. This indicates a minor update to the page's content or system without changing the study information.
    Difference
    0.1%
    Check dated 2026-06-27T00:10:12.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Recruitment status now indicates the study is no longer looking for participants. The page also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Interventions header from 'Intervention / Treatment' to 'Intervention/Treatment' with a revision note to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:31:16.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page. The main study details and user-facing information remain the same.
    Difference
    0.1%
    Check dated 2026-06-05T12:24:23.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The explicit 'Prostate cancer' label and the 'MedlinePlus Genetics' related topic linkage have been removed, along with the 'related topics' header. This changes how the study's subject is presented and which educational resources are shown to users.
    Difference
    0.2%
    Check dated 2026-05-29T08:55:10.000Z thumbnail image

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.